Print

Key management and founders

 

 

Vicenç Tur, MBA

Chief Executive Officer and co-founder

 

Mr. Tur holds a Degree in Business (UIB), in Economics (UAB) and an MBA (Stirling University, UK). Mr Tur accumulates a long and rich experience in managing R&D projects in innovative Companies and had previous experience in the financial sector. He has been advisor to the Regional Government for R&D and industrial innovation policies and has participated actively in the set-up of several technology based companies. 10+ years experience in successfully setting-up, managing and consolidating innovative projects in the biopharmaceutical space.

 

Neil Dey, PhD.

Business Development & Director of Lipopharma Inc.

 

Dr. Dey has more than 20 years of cross-functional experience in licensing, international alliances, strategic marketing, technology & product development, asset acquisition, M&A, market assessment and clinical trial management. He has held senior executive positions in several biopharmaceutical companies including LMBRI LLC, Definies Ag, Impath Inc., Genmethrax Inc. or Ciba-Geigy (Novartis)

 

Antoine Perier, DEA (C)

Clinical Development and Quality Assurance

 

Antoine has more than 25 years of experience in supporting bio-pharmaceutical companies in their general and clinical development to ensure financial and scientific optimization, and regulatory compliance. With a degree in Biology and a Master of Research (DEA) in Reproductive Biology – Endocrinology, he has held operational and executive responsibilities at Sanofi, AnalyticA, Cardinal Systems (clinical CRO where he served as CEO for 18 years) and Crane Solutions

 

Marco A. Moreno, PhD. (C)

Quality & Regulatory affairs.

 

Dr. Moreno is a regulatory affairs specialist with more than 14 years of hand on experience in regulatory affairs, having developed his career in the Spanish Regulatory Agency, Pfizer, QualitecFarma and Moreno-Santurino Regulatory & Quality Assessors. He holds a PhD in Pharmacology and is accredited as a Qualified Person (QP) with a deep knowledge of CMC and quality maters in pharmaceutical products

 

Richard J. Taylor, PhD. (C)

Medical and Regulatory affairs

 

Dr. Taylor has extensive multi-national pharmaceutical company experience. Formerly Head of International Clinical and Regulatory Affairs with Zeneca Pharmaceuticals (now AstraZeneca), Dr. Taylor has held management positions with Fisons Pharmaceuticals (now part of Aventis) and The Wellcome Research Laboratories (now part of Glaxo SmithKline). Since 2001 he is Managing Consultant & Projects Director at The Medical & Regulatory Partnership Ltd (TMRP), a drug development consultancy specializing in global regulatory professional services. Richard has a successful track record building clinical research, medical and regulatory affairs capability and has been actively involved in the preparation and update of key regulatory documents (IB, IMPD) and formal interactions with the UK Regulatory Agency (MHRA) on behalf of Lipopharma since early 2011.

 

© 2017 Lipopharma | legal notice Copyright 2011 Lipopharma - Team. All Rights Reserved.
Joomla 1.7 templates by hostgator coupon and learn how to make a website